Covid-19 roundup: US secures 100,000 doses of Eli Lilly's antibody cocktail; Merck's $356M supply deal on hold as FDA asks for more data
A couple weeks after racking up its third EUA for a Covid-19 treatment — this one for its antibody cocktail — Eli Lilly has struck a deal …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
